UY30675A1 - Metodos para el tratamiento de la depresion - Google Patents

Metodos para el tratamiento de la depresion

Info

Publication number
UY30675A1
UY30675A1 UY30675A UY30675A UY30675A1 UY 30675 A1 UY30675 A1 UY 30675A1 UY 30675 A UY30675 A UY 30675A UY 30675 A UY30675 A UY 30675A UY 30675 A1 UY30675 A1 UY 30675A1
Authority
UY
Uruguay
Prior art keywords
treatment
depression
methods
formula
present
Prior art date
Application number
UY30675A
Other languages
English (en)
Inventor
Ewa Malatynska
Magali Haas
Robert Gordon
Yong Moon Choi
Original Assignee
Sk Holdings
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30675(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sk Holdings, Janssen Pharmaceutica Nv filed Critical Sk Holdings
Publication of UY30675A1 publication Critical patent/UY30675A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion consiste en un método para el tratamiento de la depresion, que comprende la administracion, a un sujeto que lo necesita, de una cantidad terapéutica eficaz de uno o más compuestos de carbamato de la Formula 1 o de la Formula 2, como se definen en esta solicitud, y como se exponen a continuacion, para el tratamiento de la depresion: La presente invencion se dirige a un método para el tratamiento de la depresion, que comprende el monotratamiento y alternativamente, el tratamiento conjunto con por lo menos un antidepresivo adicional.
UY30675A 2006-10-30 2007-10-30 Metodos para el tratamiento de la depresion UY30675A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86340806P 2006-10-30 2006-10-30

Publications (1)

Publication Number Publication Date
UY30675A1 true UY30675A1 (es) 2008-05-02

Family

ID=39167608

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30675A UY30675A1 (es) 2006-10-30 2007-10-30 Metodos para el tratamiento de la depresion

Country Status (22)

Country Link
US (1) US20080317883A1 (es)
EP (1) EP2081648A2 (es)
JP (1) JP2010508355A (es)
KR (1) KR20090110889A (es)
CN (1) CN101568362A (es)
AR (1) AR064241A1 (es)
AU (1) AU2007313865A1 (es)
BR (1) BRPI0718324A2 (es)
CA (1) CA2667949A1 (es)
CL (1) CL2007003120A1 (es)
EA (1) EA200970436A1 (es)
EC (1) ECSP099308A (es)
IL (1) IL198484A0 (es)
MX (1) MX2009004770A (es)
NI (1) NI200900073A (es)
NO (1) NO20092018L (es)
PE (1) PE20080929A1 (es)
SV (1) SV2009003247A (es)
TW (1) TW200835477A (es)
UY (1) UY30675A1 (es)
WO (1) WO2008055022A2 (es)
ZA (1) ZA200903771B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
JP5838226B2 (ja) 2011-01-13 2016-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド フェニルカルバメート誘導体の製造方法
WO2013100566A1 (en) 2011-12-27 2013-07-04 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
US11202800B1 (en) * 2013-02-26 2021-12-21 Jeanne Fleming Methods for treating emotional cognitive disconnect
JP6200527B2 (ja) 2013-03-12 2017-09-20 バイオ−ファーム ソリューションズ カンパニー リミテッド 神経保護用フェニルカルバメート化合物及びこれを含む組成物
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝
CN116478225B (zh) * 2023-04-12 2024-06-11 南京工业大学 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20030027817A1 (en) * 1998-05-29 2003-02-06 Tollefson Gary Dennis Combination therapy for treatment of bipolar disorders
RU2302240C2 (ru) * 2001-02-27 2007-07-10 Орто-Макнейл Фармасьютикал, Инк. Производные карбаматов для предотвращения или лечения психотических нарушений
US6562867B2 (en) * 2001-02-27 2003-05-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating bipolar disorder
NZ527989A (en) * 2001-02-27 2005-12-23 Ortho Mcneil Pharm Inc Use of a halogenated 2-phenyl-1,2-ethanediol dicarbamate enantiomer or enantiomeric mixture wherein one enantiomer predominates for preventing or treating bipolar disorder
DE60220043T2 (de) * 2001-02-27 2008-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
CA2587481A1 (en) * 2004-10-28 2006-05-11 Sk Corporation Phenylalkylamino carbamates adjunctive therapy for depression

Also Published As

Publication number Publication date
WO2008055022A3 (en) 2008-06-19
ZA200903771B (en) 2010-08-25
WO2008055022A2 (en) 2008-05-08
IL198484A0 (en) 2011-08-01
MX2009004770A (es) 2009-08-17
JP2010508355A (ja) 2010-03-18
EP2081648A2 (en) 2009-07-29
AU2007313865A1 (en) 2008-05-08
BRPI0718324A2 (pt) 2013-11-26
PE20080929A1 (es) 2008-07-19
NI200900073A (es) 2010-02-25
TW200835477A (en) 2008-09-01
ECSP099308A (es) 2009-10-30
EA200970436A1 (ru) 2009-12-30
AR064241A1 (es) 2009-03-25
SV2009003247A (es) 2009-11-24
CN101568362A (zh) 2009-10-28
NO20092018L (no) 2009-05-26
CL2007003120A1 (es) 2008-07-18
US20080317883A1 (en) 2008-12-25
CA2667949A1 (en) 2008-05-08
KR20090110889A (ko) 2009-10-23

Similar Documents

Publication Publication Date Title
UY30675A1 (es) Metodos para el tratamiento de la depresion
CR10748A (es) Compuesto de indol
EA200802428A1 (ru) Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян
CR10165A (es) "uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento de depresión"
GT200500213A (es) Composiciones fungicidas
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
AR060089A1 (es) Tratamiento del dolor
EA201290919A1 (ru) Индазольные соединения и их применение
CR9753A (es) Agente terapeutico para diabetes
CR11292A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
HN2008000792A (es) Compuesto de cinamida biciclico
EA201200098A1 (ru) Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия
ECSP067120A (es) 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas
DE602006015963D1 (de) Immunstimulatorisches verfahren
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
GT200500063A (es) Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
GT200800138A (es) Combinacion de un inhibidor de acetilcolinesterasa y un agonista de 5-ht6 para el tratamiento de disfuncion cognitiva
GT200500310A (es) Compuestos organicos
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
UY29417A1 (es) Agentes endoparasiticidas